Barclays Capital Starts DXC Technology (DXC) Coverage with $90.00 Target; 4 Bullish Analysts Covering BioDelivery Sciences International, Inc. (BDSI)

May 25, 2017 - By Louis Casey

Among 5 analysts covering BioDelivery Sciences International (NASDAQ:BDSI), 4 have Buy rating, 0 Sell and 1 Hold. Therefore 80% are positive. BioDelivery Sciences International had 10 analyst reports since August 16, 2015 according to SRatingsIntel. The firm has “Hold” rating given on Wednesday, May 11 by Cantor Fitzgerald. Piper Jaffray initiated it with “Overweight” rating and $6 target in Monday, February 8 report. Roth Capital maintained it with “Buy” rating and $9 target in Friday, March 11 report. The company was maintained on Sunday, August 16 by William Blair. Cantor Fitzgerald upgraded the shares of BDSI in report on Wednesday, May 17 to “Overweight” rating. The stock of BioDelivery Sciences International, Inc. (NASDAQ:BDSI) earned “Buy” rating by Janney Capital on Friday, September 23. The rating was maintained by Piper Jaffray on Thursday, May 12 with “Overweight”. The stock of BioDelivery Sciences International, Inc. (NASDAQ:BDSI) earned “Mkt Perform” rating by FBR Capital on Tuesday, November 10. The firm has “Neutral” rating given on Tuesday, October 27 by Janney Capital. Cantor Fitzgerald initiated BioDelivery Sciences International, Inc. (NASDAQ:BDSI) on Wednesday, November 4 with “Buy” rating. See BioDelivery Sciences International, Inc. (NASDAQ:BDSI) latest ratings:

17/05/2017 Broker: Cantor Fitzgerald Old Rating: Neutral New Rating: Overweight Upgrade

Among 4 analysts covering DXC Technology (NYSE:DXC), 4 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. DXC Technology has $90 highest and $87 lowest target. $88.50’s average target is 12.54% above currents $78.64 stock price. DXC Technology had 4 analyst reports since April 4, 2017 according to SRatingsIntel. The rating was initiated by JP Morgan on Wednesday, April 19 with “Overweight”. The rating was initiated by RBC Capital Markets on Tuesday, April 4 with “Outperform”. As per Thursday, April 6, the company rating was upgraded by Morgan Stanley. The company was maintained on Tuesday, April 11 by Citigroup.

The stock increased 0.89% or $0.69 during the last trading session, reaching $78.64. About 1.70 million shares traded. DXC Technology Company (NYSE:DXC) has risen 126.68% since May 25, 2016 and is uptrending. It has outperformed by 109.98% the S&P500.

Since December 1, 2016, it had 0 buys, and 9 sales for $616,568 activity. Shares for $1,425 were sold by ODONNELL FRANCIS E JR. SEARS SAMUEL P JR also sold $20,040 worth of BioDelivery Sciences International, Inc. (NASDAQ:BDSI) on Thursday, December 1. Shares for $323 were sold by De Paolantonio Ernest Robert on Wednesday, March 22. Shares for $1,007 were sold by Vasisht Niraj. The insider Sirgo Mark A sold 110,895 shares worth $210,920.

Investors sentiment decreased to 0.75 in Q4 2016. Its down 0.07, from 0.82 in 2016Q3. It is negative, as 17 investors sold BioDelivery Sciences International, Inc. shares while 19 reduced holdings. 9 funds opened positions while 18 raised stakes. 20.48 million shares or 22.10% less from 26.28 million shares in 2016Q3 were reported. Sigma Planning stated it has 20,259 shares. Stephens Ar has invested 0% in BioDelivery Sciences International, Inc. (NASDAQ:BDSI). Venbio Select Advisor Ltd Liability holds 0.23% or 644,176 shares in its portfolio. Manufacturers Life Ins Communications The, Ontario – Canada-based fund reported 1,452 shares. Grt invested 0.14% in BioDelivery Sciences International, Inc. (NASDAQ:BDSI). Credit Suisse Ag has invested 0% in BioDelivery Sciences International, Inc. (NASDAQ:BDSI). California Pub Employees Retirement holds 0% of its portfolio in BioDelivery Sciences International, Inc. (NASDAQ:BDSI) for 262,900 shares. Blackrock Fund Advsrs has 146,064 shares for 0% of their portfolio. Ameriprise Fincl has invested 0% of its portfolio in BioDelivery Sciences International, Inc. (NASDAQ:BDSI). Blackrock Advisors Limited Liability Corp owns 8,009 shares or 0% of their US portfolio. Price T Rowe Associates Md has invested 0% in BioDelivery Sciences International, Inc. (NASDAQ:BDSI). Us Natl Bank De invested 0% of its portfolio in BioDelivery Sciences International, Inc. (NASDAQ:BDSI). Cutter And Brokerage holds 0.03% in BioDelivery Sciences International, Inc. (NASDAQ:BDSI) or 38,280 shares. Moreover, Buckingham Asset Ltd Liability has 0.02% invested in BioDelivery Sciences International, Inc. (NASDAQ:BDSI). Earnest Ptnrs Ltd Liability Com holds 0% or 2,800 shares in its portfolio.